Twist Bioscience stockholders elect three directors, approve say-on-pay and auditor ratification at 2026 annual meeting

Twist Bioscience Corp

Keith Crandell, Jan Johannessen, and Trynka Shineman Blake elected as Class II directors with over 40M votes for each.
Non-binding advisory vote to approve NEO compensation passed: 38.4M for, 11.8M against, 32.7K abstentions.
Ratification of Ernst & Young as auditor for FY2026 approved: 56.2M for, 18.2K against, 21.8K abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.